Pauls Dietrich John
SEC CIK 1760123 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| DMAC | DiaMedica Therapeutics Inc. | Pres, CEO, Dir | 128.8K | $89.9K | — | 4 | 2021-08-16 | 2026-08-10 |
Most active insiders at DMAC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | TRILL AB | 10% | $7.63M | — |
| 2 | Semba Charles Pauling | Dir | — | — |
| 3 | Pauls Dietrich John | Pres, CEO, Dir | — | — |
| 4 | Parsons James T. | Dir | — | — |
| 5 | Giuffre Randall Michael | Dir | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-12 16:23 | 2026-08-10 | DMAC | DiaMedica Therapeutics Inc. | Pauls Dietrich John | Pres, CEO, Dir | A - Grant | $0.00 | +60.2K | 128.8K | +88% | $0 | |
| 2023-06-26 | 2023-06-23 | DMAC | DiaMedica Therapeutics Inc. | Pauls Dietrich John | Pres, CEO, Dir | P - Purchase | $3.91 | +12.8K | 68.6K | +23% | +$50.0K | |
| 2022-11-16 | 2022-11-16 | DMAC | DiaMedica Therapeutics Inc. | Pauls Dietrich John | Pres, CEO, Dir | P - Purchase | $1.21 | +20.0K | 55.8K | +56% | +$24.2K | |
| 2021-08-16 | 2021-08-16 | DMAC | DiaMedica Therapeutics Inc. | Pauls Dietrich John | Pres, CEO, Dir | P - Purchase | $3.14 | +5,000 | 35.8K | +16% | +$15.7K |
Purchase Sale Sale after option exercise All abbreviations